- Filed
- Aug 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Aug 14, 2025 | 6.75M sh |
| Shares Diluted | Q1 2025 · Jun 30, 2025 | 6.75M sh |
| Shares Diluted | Q1 2025 · Jun 30, 2024 | 6.75M sh |
| Capex | Q1 2025 · Jun 30, 2025 | $3.73M |
| Capex | Q1 2025 · Jun 30, 2024 | $369K |
| Operating Cash Flow | Q1 2025 · Jun 30, 2025 | $912K |
| Operating Cash Flow restated | Q1 2025 · Jun 30, 2024 | −$438K |
| Cash And Equivalents | Q1 2025 · Jun 30, 2025 | $22.03M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $24.52M |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $40.63M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $18.98M |
| Stockholders Equity | Q1 2025 · Jun 30, 2025 | $52.47M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $53.14M |
| Current Liabilities | Q1 2025 · Jun 30, 2025 | $4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.9M |
| Total Liabilities | Q1 2025 · Jun 30, 2025 | $12.55M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.65M |
| Current Assets | Q1 2025 · Jun 30, 2025 | $25.36M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $27.44M |
| Total Assets | Q1 2025 · Jun 30, 2025 | $78.93M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $77.67M |
| Eps Diluted | Q1 2025 · Jun 30, 2025 | −$0.11 |
| Eps Diluted | Q1 2025 · Jun 30, 2024 | −$0.49 |
| Eps Basic | Q1 2025 · Jun 30, 2025 | −$0.11 |
| Eps Basic | Q1 2025 · Jun 30, 2024 | −$0.49 |
| Sga Expense | Q1 2025 · Jun 30, 2025 | $2.23M |
| Sga Expense restated | Q1 2025 · Jun 30, 2024 | $3.79M |
| Net Income | Q1 2025 · Jun 30, 2025 | −$748K |
| Net Income restated | Q1 2025 · Jun 30, 2024 | −$3.3M |
| Operating Income | Q1 2025 · Jun 30, 2025 | −$986K |
| Operating Income restated | Q1 2025 · Jun 30, 2024 | −$3.57M |
| Revenue | Q1 2025 · Jun 30, 2025 | $3.03M |
| Revenue | Q1 2025 · Jun 30, 2024 | $489K |